drug interactions
TRANSCRIPT
DRUG DRUG INTERACTIONSINTERACTIONS
1
Ciciliya VJ
Drug interaction can be defined as the modifications of the effects of one drug by the prior, concomitant or subsequently administered another drug .
Drug interactions can be either Harmful or Beneficial.
6.5% of adverse drug reactions in USA were attributed to drug interactions (0.2% of these patients may have life-treatening interactions)
The potential drug interactions has been observed to be 17% in surgical patients, 22% in patients in medical wards, 23% in out patients clinics.
2
Today the potential for “DI” is high due to the availability of complex therapeutic agents and wide spread poly pharmacy.
Pharmacist play a valuable role in screening of interaction and advising on management when interactions occur.
This may be at the patient bed side, as part of the dispensing process or during the sale of non-prescription medicine.
A role of current emerging importance is the detection of interactions between medicines and other pharmacologically active therapies,such as herbal and alternative remedies.
3
Drug interactions represent 3–5% of preventable in-hospital ADRs
Drug interactions are also an important cause of patient visits to physicians and emergency departments.
Contribution of Drug Interactions Contribution of Drug Interactions to the Overall Burden of to the Overall Burden of
Preventable ADRsPreventable ADRs
4
Pharmacokinetic interactions-Absorption-Distribution-Metabolism-Excretion
Pharmacodynamic interactions -Pharmacological Synergism -Pharmacological antagonismPhysiological interactionsPharmaceutical interactions
Mechanism of drug interactionMechanism of drug interaction
5
One drug alters the rate or extent of absorption, distribution, metabolism or excretion of another drug.
A change in blood concentration causes a change in the drug’s effect.
Pharmacokinetic Drug Pharmacokinetic Drug InteractionsInteractions
6
Important interactions that lead to the modification of drug absorption are largely associated with the GIT.
Interactions in the GIT significantly reduce or increase the amount of drug that absorbed into the body.
Some interactions have been used adventageously with parenteral formulations
eg:- adrenaline (vasoconstrictor)- used to slow the absorption of local anaesthetic to prolong anaesthesia.
Drug AbsorptionDrug Absorption
7
Change in gastrointestinal pH -Ketoconazole needs acidic conditions in
gutDrug binding in GI tract -E.g. tetracycline and calciumChange in gastrointestinal flora -Antibiotics with OCs Change in gastrointestinal motility -Metoclopramide and digoxinMalabsorption caused by other drugs -Orlistat (Xenical) and fat soluble vitamins
Altered AbsorptionAltered Absorption
8
CHELATION
Heavy metal ions such as iron,calcium ,magnesium and zinc can bind to anionic medicines like ciprofloxacin and tetracycline. This produce a poorly soluble salt form that does not dissolve quickly.
Ion exchange resins can also bind medicines and prevent absorption.
For example:cholestyramine bind to bile salts and lower serum cholesterol,can bind drugs such as thyroxine,digoxin and warfarin and reduces their absorption.
Therapeutic failure has been reported with these medicines.
9
CHANGES IN GI MOTILITY
Some drugs alter the rate of passage of drugs through the GIT.
This commonly changes the rate of absorption. eg: 1)metoclopromide increases the gastro intestinal
motility and more importantly for medicines absorbed under the basic conditions of the duodenum and jejunum,opens pyloric sphincter at the stomach outlet.
Eg : Metoclopromide and paracetamol
2)Metoclopromide and digoxin-by metoclopromide less time for digoxin to dissolve less will be absorbed therapeutic failure can occur
10
BOWEL FLORA EFFECT
Some medicines can alter the normal microorganism population in the large intestines;these organism plays important role in the kinetics and action of some drugs
Eg:The modification of bowel bacteria by broad spectrum antibiotics can also indirectly affect the activity of coumarin anticoagulants.
These antibiotic can reduce the population of bowel bacteria that synthesise vit K reduce drug absorbed into the body.
Vit K antagonise the action of coumarin anti coagulants Reducing vit k absorption increase the action of
warfarin,will increase bleeding.
11
PROTEIN – BINDING DISPLACEMENT
Interactions altering drug distribution commonly associated with drugs that bound to plasma proteins being displaced by another drug .
concentration of free drug in plasma will increase exposing the drug to the normal elimination,also the levels are rapidly reduced.
eg:displacement of methotrexate or warfarin from protein binding by aspirin or other NSAIDs(phenybutazone).
DRUG DISTRIBUTIONDRUG DISTRIBUTION
12
Interaction occurs through the induction or inhibition of drug metabolism.
METABOLIC INDUCTIONOne drug increases the metabolism of
another,will decrease the level of substrate in the body and increase the levels of metabolite.
Eg:- phenytoin phenobarbitone and carbamazepine are potent inducers of cytochrome CYP3A4.
-rifampicin-potent inducer of CYP3A4
METABOLISMMETABOLISM
13
METABOLIC INHIBITION Inhibition of drug will increase its plasma
levels with the potential for toxicity or enhanced risk of side effects,if the parent drug is the active species.
decreased metabolism of concomitant drug therefore decreased drug excretion and increased drug effect.
eg:diltiazem inhibit CYP3A4 has been used with cyclosporin.
14
DRUG TRANSPORTER INTERACTION
Drug transporter which carry drug across cell membrane into cell and or out of cell.
Eg:1.digoxin erythromycin interaction(P-GLYCOPROTEIN,Inhibition by erythromycin occurs)
2.colchicine is transported by Pgp and verapamil can inhibit the transporter.
GENETIC POLYMORPHISM AND DRUG INTERACTION
Genetic polymorphism occurs with CYP2D6,2C19 but not CYP3A4 or 1A2.
15
Drug A increases or reduces the excretion (usually renal) of Drug B.
Blood levels of B fall below or rise above normal therapeutic range.
Becomes either ineffective or toxic.
EXCRETIONEXCRETION
16
Drugs eliminated by kidneys – alteration in urinary pH, tubular secretion and rate of glomerular flow can alter the amount of drug that is excreted
Lithium + Thiazide diuretics
Excretion InteractionsExcretion Interactions
17
PHARMACOLOGICAL SYNERGISM Synergism occurs when two drugs with a similar
pharmacological or side effects are given together produce an additive effect.
Combination of drugs given for therapeutic advantage
eg:opiates and TCAs-pain control
PHARMACODYNAMIC PHARMACODYNAMIC INTERACTION MECHANISMINTERACTION MECHANISM
18
Some combination results in side effects eg:ACE inhibitor with aldosterone
antagonist,spironolactone cause hyperkalemia.
Serious and life threatening is non reversible MAO inhibitor(phenelzine) with SSRI(Sertaline) results in increased neurotransmitter serotonin and precipitate serotonin syndrome.
19
PHARMACOLOGICAL ANTAGONISM
One drug prevents the pharmacological action of another
eg: 1)thiazide diuretics+NSAIDs reduce diuretic activity.
2)TCA+Antiepileptics lower the seizure threshold.
3)metoclopromide+levodopa block the beneficial effect of dopamine precursor
20
Substrate:Drug is metabolised by the enzyme system
Inducer:Drug that will increase the synthesis of CYP450 enzymes
InhibitorDrug that will decrease the metabolism of a substrate
CYP 450 SystemCYP 450 SystemDefinitionsDefinitions
21
CYP2D6
CYP450 NomenclatureCYP450 NomenclatureFamily
Sub-Family
Individual Gene
22
CYP = cytochrome P450 2 = genetic family D = genetic sub-family 6 = specific gene
Example : CYP2D6Example : CYP2D6
23
Responsible for metabolism of: -Most calcium channel blockers -Most benzodiazepines -Most HIV protease inhibitors -Most HMG-CoA-reductase inhibitors -Most non-sedating antihistamines -Cyclosporine
Present in GI tract and liver
Cytochrome P450 3ACytochrome P450 3A
24
Absent in 7-9% of Caucasians, 1–2% of non-Caucasians
Over-expressed in up to 30% of East Africans
Catalyzes primary metabolism of: Codeine Many -blockers Many tricyclic antidepressants Inhibited by: Fluoxetine Haloperidol Paroxetine Quinidine
Cytochrome P450 2D6Cytochrome P450 2D6
25
Absent in 1% of Caucasians and African-Americans
Primary metabolism of:- Most NSAIDs (including COX-2)- S-warfarin (the active isomer)- Phenytoin
Inhibited by fluconazole
Cytochrome P450 2C9Cytochrome P450 2C9
26
Absent in 20–30% of Asians, 3–5% of Caucasians
Primary metabolism of: Diazepam Phenytoin Omeprazole ClopidogrelInhibited by: Omeprazole Isoniazid Ketoconazole
Cytochrome P450 2C19Cytochrome P450 2C19
27
Induced by smoking tobaccoCatalyzes primary metabolism of: Theophylline Imipramine Propranolol ClozapineInhibited by: Many fluoroquinolone antibiotics Fluvoxamine Cimetidine
Cytochrome P450 1A2Cytochrome P450 1A2
28
1. Take a medication history (AVOID Mistakes mnemonic)
2. Remember high-risk patients - Any patient taking ≥ 2 medications - Patients treated with anticonvulsants, antibiotics, digoxin,warfarin, amiodarone, etc. 3. Check pocket reference or PDA 4. Consult pharmacists or drug info specialists 5. Check up-to-date computer program -Medical Letter Drug Interaction Program* - www.epocrates.com* and others
Drug-Drug Interaction Prevention: Drug-Drug Interaction Prevention:
A Stepwise ApproachA Stepwise Approach
29
Allergies?Vitamins and herbs?Old drugs and OTC? (as well as current)Interactions? Dependence? Do you need a contract?Mendel: Family Hx of benefits or problems
with any drugs?
A Good Medication History:A Good Medication History:AVOID MAVOID Mistakesistakes
30
Evaluate drug interaction risk on a patient specific basis.
Offer non interacting alternatives to victim or precipitator drugs wherever possible.
If non interacting alternatives are unavailable, use low risk precipitator drugs and/or find a victim drug with parallel metabolic path ways.
If interacting drug must be used concomitantly take steps to mitigate the interaction such as staggering administration times or changing dosage forms. 31
Monitor the patient if it appears that the chance of interaction is high and the out come is likely to be clinically meaningful
Look at any sudden change in patient status as a potential result of a drug interaction and investigate. Remember that starting or stopping a precipitator drug can affect a victim drug and patient status.
Educate all health care professionals about the potential risks of drug interactions.
32
Drug A and Drug B bind to different receptors on the same tissue but give opposite or similar effect Aspirin (anti-platelet) +Warfarin/Coumarin (anticoagulant) Increase bleeding
Physiological InteractionsPhysiological Interactions
33
Adrenaline constricts the blood vessels but histamine dilates it
Adrenergics decrease GI motility but cholinergics increases the motility
34
Phenytoin precipitates in IV dextrose solutions (e.g., D5W)
AmphotericinB precipitates in IV saline
Gentamicin is physically/chemically incompatible when mixed with most beta-lactam antibiotics, resulting in loss of both antibiotics’ effects
Pharmaceutical InteractionsPharmaceutical Interactions
35
Use of wrong vehicle for infusion-no drug addition to blood,plasma,amino acid, fat,emulsions,mannitol,heparin, sod.bicarbonate.
Higly acidic solns.like dextrose,fructose are unsuitable for sod. Or pot. Salts of weakly acidic drugs.
Isotonic saline is suitable for most drugs except NA
36
Drug-Food interactionsDrug-Food interactions
• Grapefruit juice and Terfenadine• Grapefruit juice and cyclosporin• Grapefruit juice and felodipine• Grapefruit contains : furanocoumarin
compounds that can selectively inhibit CYP3A4
• Tetracycline and milk products• Warfarin and vitamin K-containing
foods37
Potentially dangerous interaction between drug and food.
eg:MAO inhibitors (phenelzine)with tyramine containing foods results metabolic blockade by phenelzine can precipitate potentially fatal hypertensive crisis.
Some results therapeutic failure eg:phenytoin with enteral feeding
mixture.,decrease GI absorption.High diet fibre increase warfarin activity by
impairing absorption of vit KGrape fruit inhibit GI metabolism of
medicines handled by CYP3A4 isoenzyme.Chilli inhibit substance P and is reported to
increase the incidence of coughing in patients on ACE inhibitor. 38
Ginkgo biloba Drug-Herb interactionsDrug-Herb interactions
39
St. John’s wort: CYP3A4 inducerSt. John’s wort: CYP3A4 inducer
40
St. John’s Wort with:IndinavirCyclosporineDigoxinTacrolimusPossibly many others
Drug-Herbal InteractionsDrug-Herbal Interactions
41
List of the most common interacting drug-Antacids-Cimetidine-Digoxin -Warfarin-Theophylline-Ketoconazole
42
Liver diseaseRenal disease Cardiac disease Acute myocardial infarction
Drug-Disease InteractionsDrug-Disease Interactions
43
Combination of antihypertensives for the treatment of hypertention.
Combination of antibiotics to treat an infection.
Combination of epinephrine with lidocaine to prolong anesthetic effects.
Combination of statins with ezetimibe to treat dislipidemia.
Antidotes like naloxone and flumazenil .Combination of hypoglycemic agents to
treat diabetes.
Beneficial Effects of Drug Beneficial Effects of Drug InteractionsInteractions
44
Beneficial pharmacokinetic interactions are much less compared to pharmacodynamic interactions.
Probenecid with penicillin to elevate pencillin level in serum.
Ketoconazole and diltiazem with cyclosporine or tarcolimus to elevate serum levels of these immunosupresants.
P-glycoprotein inhibitors like clarithromycin,ketoconazole etc may improve the response of protease inhibitors in HIV treatment; improve response to anticonvulsants in refractory epilepsy
45
The role of pharmacist in preventing and detecting interaction and providing reliable advice on interaction management can greately add to patient’s safety and wellbeing.
46